CRESCENT BIOPHARMA, INC. Accrued Bonuses, Current
CRESCENT BIOPHARMA, INC. (CBIO) had Accrued Bonuses, Current of $666.62 thousand as of 2024-03-31, per its 10-Q filed 2024-05-09.
Financial Statements › Notes › Accrued Liabilities, Current › Employee-related Liabilities, Current
us-gaap:AccruedBonusesCurrent · last filed 2025-02-13
- 2024-03-31: Accrued Bonuses, Current $666.62K.
- 2023-12-31: Accrued Bonuses, Current $2.56M.
- 2023-09-30: Accrued Bonuses, Current $1.72M.
- 2023-06-30: Accrued Bonuses, Current $1.80M.
| Period end | Accrued Bonuses, Current |
|---|---|
| 2024-03-31 | $666.62K 10-Q · filed 2024-05-09 |
| 2023-12-31 | $2.56M 10-K · filed 2025-02-13 |
| 2023-09-30 | $1.72M 10-Q · filed 2023-11-03 |
| 2023-06-30 | $1.80M 10-Q · filed 2023-08-02 |
| 2023-03-31 | $1.10M 10-Q · filed 2023-05-03 |
| 2022-12-31 | $2.66M 10-K · filed 2024-03-27 |
| 2022-09-30 | $1.74M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $1.93M 10-Q · filed 2022-08-03 |
| 2022-03-31 | $1.05M 10-Q · filed 2022-04-28 |
| 2021-12-31 | $2.15M 10-K · filed 2023-03-29 |
| 2021-09-30 | $1.70M 10-Q · filed 2021-11-02 |
| 2021-06-30 | $2.00M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $1.32M 10-Q · filed 2021-05-03 |
| 2020-12-31 | $3.34M 10-K · filed 2022-03-03 |
| 2020-09-30 | $2.35M 10-Q · filed 2020-11-06 |
| 2020-06-30 | $2.04M 10-Q · filed 2020-07-31 |
| 2020-03-31 | $1.17M 10-Q · filed 2020-05-01 |
| 2019-12-31 | $2.68M 10-K · filed 2021-03-02 |
| 2019-09-30 | $1.65M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $1.08M 10-Q · filed 2019-08-01 |
| 2019-03-31 | $517.36K 10-Q · filed 2019-05-02 |
| 2018-12-31 | $1.73M 10-K · filed 2020-02-28 |
| 2018-09-30 | $1.29M 10-Q · filed 2018-11-02 |
| 2018-06-30 | $852.08K 10-Q · filed 2018-08-09 |
| 2018-03-31 | $441.57K 10-Q · filed 2018-05-03 |
| 2017-12-31 | $1.88M 10-K · filed 2019-03-06 |
| 2017-09-30 | $1.15M 10-Q · filed 2017-11-08 |
| 2017-06-30 | $766.46K 10-Q · filed 2017-08-03 |
| 2017-03-31 | $387.94K 10-Q · filed 2017-05-08 |
| 2016-12-31 | $1.43M 10-K · filed 2018-03-06 |
| 2016-09-30 | $826.46K 10-Q · filed 2016-11-04 |
| 2016-06-30 | $552.59K 10-Q · filed 2016-08-04 |
| 2016-03-31 | $276.00K 10-Q · filed 2016-05-04 |
| 2015-12-31 | $1.04M 10-K · filed 2017-03-01 |
| 2015-09-30 | $695.51K 10-Q · filed 2015-11-12 |
| 2015-06-30 | $446.90K 10-Q · filed 2015-08-06 |
| 2015-03-31 | $226.01K 10-Q · filed 2015-05-05 |
| 2014-12-31 | $753.79K 10-K · filed 2016-02-29 |
| 2014-09-30 | $568.84K 10-Q · filed 2014-10-31 |
| 2014-06-30 | $372.76K 10-Q · filed 2014-07-31 |
| 2014-03-31 | $177.50K 10-Q · filed 2014-05-09 |
| 2013-12-31 | $344.47K 10-K · filed 2015-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |